Diagnostic Performance of the Cytomegalovirus (CMV) Antigenemia Assay in Patients with CMV Gastrointestinal Disease

被引：61

作者：

Jang, Eun-Young ^{[1
]}

Park, Seong Yeon ^{[1
]}

Lee, Eun Jung ^{[1
]}

Song, Eun Hee ^{[1
]}

Chong, Yong Pill ^{[1
]}

Lee, Sang-Oh ^{[1
]}

Choi, Sang-Ho ^{[1
]}

Woo, Jun Hee ^{[1
]}

Kim, Yang Soo ^{[1
]}

Kim, Sung-Han ^{[1
]}

机构：

[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Infect Dis, Seoul 138736, South Korea

来源：

CLINICAL INFECTIOUS DISEASES | 2009年 / 48卷 / 12期

关键词：

STEM-CELL TRANSPLANTATION; MARROW-TRANSPLANTATION; PREEMPTIVE THERAPY; RECIPIENTS; UTILITY;

D O I：

10.1086/599116

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Of 149 patients with suspected cytomegalovirus (CMV) gastrointestinal disease, 51 (36%) confirmed cases, 6 (4%) probable cases, and 64 (45%) instances of non-CMV gastrointestinal disease were analyzed using the CMV antigenemia assay; 22 patients (5%) with indeterminate gastrointestinal disease were excluded. The sensitivity and specificity of the CMV antigenemia assay (defined as detection of >= 1 positive cells per 200,000 leukocytes) for diagnosis of CMV gastrointestinal disease were 54% (95% confidence interval, 41%-68%) and 88% (95% confidence interval, 77%-94%), respectively.

引用

页码：E121 / E124

页数：4

共 50 条

[41] Comparison of cytomegalovirus (CMV) antigenemia and CMV in bronchoalveolar lavage fluid for diagnosis of CMV pulmonary infection after bone marrow transplantation
H Sakamaki
K Yuasa
H Goto
S Tanikawa
H Akiyama
Y Onozawa
R Okamoto
Y Maeda
T Sasaki
H Kaku
S Tsuzuki
S Takamoto
Y Mochida
T Minematsu
Y Minamishima
Bone Marrow Transplantation, 1997, 20 : 143 - 147
[42] Clinical significance of cytomegalovirus (CMV) pp65 antigenemia in the prediction of CMV infection during immunosuppressive therapy for rheumatic disease
Suga, Kensuke
Nishiwaki, Aya
Nakamura, Takayuki
Kagami, Shin-Ichiro
RHEUMATOLOGY INTERNATIONAL, 2023, 43 (06) : 1093 - 1099
[43] Indication of ganciclovir treatment during early cytomegalovirus (CMV) viremia in CMV seropositive recipients. A longitudinal study of CMV pp65 antigenemia (Ag) assay.
Yang, CW
An, HJ
Kim, YO
Shin, YS
Chang, YS
Bang, BK
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A3404 - A3404
[44] Optimal indication of gancyclovir treatment during early cytomegalovirus (CMV) viremia in CMV seropositive recipients. A longitudinal study of CMV pp65 antigenemia assay.
Yang, CW
Lee, SH
Yoon, SN
An, HJ
Kim, YO
Shin, YS
Kim, YS
Choi, EJ
Bang, BK
KIDNEY INTERNATIONAL, 1997, 51 (03) : 961 - 961
[45] Tissue invasive cytomegalovirus (CMV) disease without antigenemia in solid organ transplant recipients
McDermid, J
Gourishankar, S
Wong, CKW
GASTROENTEROLOGY, 2004, 126 (04) : A512 - A513
[46] Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients
Spector, SA
Wong, R
Hsia, K
Pilcher, M
Stempien, MJ
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (02): : 497 - 502
[47] Quantitative CMV antigenemia correlated with ophthalmoscopic screening for CMV retinitis in AIDS patients
Fezza, J
Weitzman, M
Shoemaker, D
Gremillion, C
Chen, H
OPHTHALMIC SURGERY AND LASERS, 2001, 32 (01): : 81 - 82
[48] QUANTITATIVE CMV ANTIGENEMIA CORRELATED WITH OPHTHALMOSCOPIC SCREENING FOR CMV RETINITIS IN AIDS PATIENTS
FEZZA, J
WEITZMAN, M
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1995, 36 (04) : S320 - S320
[49] Comparison of nested PCR and antigenemia arrays for detection of cytomegalovirus (CMV) in transplant patients.
Montenegro-James, S
Garcia-Diaz, J
Kohli, T
Hutchinson, L
CLINICAL INFECTIOUS DISEASES, 2000, 31 (01) : 317 - 317
[50] Comparative study of cytomegalovirus (CMV) antigenemia assay, polymerase chain reaction, serology, and shell vial assay in the early diagnosis and monitoring of CMV infection after renal transplantation
Tanabe, K
Tokumoto, T
Ishikawa, N
Koyama, I
Takahashi, K
Fuchinoue, S
Kawai, T
Koga, S
Yagisawa, T
Toma, H
Ota, K
Nakajima, H
TRANSPLANTATION, 1997, 64 (12) : 1721 - 1725

← 1 2 3 4 5 →